Metformin
-
Stanford Study Points to Potential Survival Benefit for Diabetes Patients Taking Metformin
A Stanford study reveals type 2 diabetes patients taking metformin before COVID-19 had a 39% lower one-year mortality risk, signaling broader health benefits.
-
Breakthrough: Metformin’s Brain Mechanism Discovered
Scientists uncover how metformin impacts brain pathways to regulate blood sugar, opening doors to new diabetes treatments and aging research.